Who is affected by peptic ulcers




















Aliment Pharmacol Ther. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori , and smoking. J Clin Gastroenterol. Ziegler AB. The role of proton pump inhibitors in acute stress ulcer prophylaxis in mechanically ventilated patients. Dimens Crit Care Nurs. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease.

Correlation between cag pathogenicity island composition and Helicobacter pylori -associated gastroduodenal disease. Infect Immun. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Helicobacter pylori -negative duodenal ulcers: prevalence, clinical characteristics, and prognosis—results from a randomized trial with 2-year follow-up. Am J Gastroenterol. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in pepticulcer disease: a meta-analysis.

Graham DY. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori , and ulcers: where we stand. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Evidence of aspirin use in both upper and lower gastrointestinal perforation. Taking a calculated risk: predictive scoring systems in dyspepsia. Scand J Gastroenterol Supp.

Cappell MS. Gastric and duodenal ulcers during pregnancy. Gastroen-terol Clin North Am. Absence of abdominal pain in older persons with endoscopic ulcers: a prospective study. Martinez JP, Mattu A. Abdominal pain in the elderly. Emerg Med Clin North Am. Hassall E. Peptic ulcer disease and current approaches to Helicobacter pylori. J Pediatr. American Gastroenterological Association technical review on the evaluation of dyspepsia. Update on Helicobacter pylori treatment. Am Fam Physician. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.

Arch Intern Med. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial MACLOR study. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer. Eur J Gastroenterol Hepatol. Vakil N, Fennerty MB.

Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease.

Behrman SW. Management of complicated peptic ulcer disease. Arch Surg. Risk factors associated with refractory peptic ulcers. Peura DA. Prevention of non-steroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications.

Am J Med. Laparoscopic management of acid peptic disease. Surg Laparosc Endosc Percutan Tech. J Clin Epidemiol. Ebell MH. Prognosis in patients with upper GI bleeding. Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay—results from the Cochrane Collaboration.

Standards of Practice Committee. An annotated algorithmic approach to upper gastrointestinal bleeding. Gastrointest Endosc. Meta-analysis: Helicobacter pylori eradication therapy vs. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs.

A randomized, double-blind, placebo-controlled trial. Ann Intern Med. Cochrane Database Syst Rev. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg. Malignancy is the most common cause of gastric outlet obstruction in the era of H2 blockers. This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference.

This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.

Contact afpserv aafp. The pain most often. Even if your symptoms are mild, you may have a peptic ulcer. You should see your doctor to talk about your symptoms. Without treatment, your peptic ulcer can get worse. Nonsteroidal anti-inflammatory drugs reduce pain, fever, and inflammation, or swelling.

NSAIDs work by blocking or reducing the amount of these enzymes that your body makes. Email address. First Name let us know your preferred name. Last Name. Thank you for subscribing Your in-depth digestive health guide will be in your inbox shortly. Sorry something went wrong with your subscription Please, try again in a couple of minutes Retry. Request an Appointment at Mayo Clinic. Share on: Facebook Twitter.

Show references Kellerman RD, et al. Gastritis and peptic ulcer disease. In: Conn's Current Therapy Elsevier; Accessed July 8, Peptic ulcer disease.

American College of Gastroenterology. Peptic ulcers stomach ulcers. Feldman M, et al. Saunders Elsevier; Nehra AK, et al. Proton pump inhibitors: Review of emerging concerns. Mayo Clinic Proceedings. Peptic ulcer disease adult. Mayo Clinic; Complications of stomach ulcers are relatively uncommon, but they can be very serious and potentially life threatening.

Read more about the complications of stomach ulcers. Page last reviewed: 17 September Next review due: 17 September Signs and symptoms The most common symptom of a stomach ulcer is a burning or gnawing pain in the centre of the tummy abdomen. When to seek medical advice You should visit your GP if you think you may have a stomach ulcer. Seek urgent medical advice if you experience any of the following symptoms: vomiting blood — the blood can appear bright red or have a dark brown, grainy appearance, similar to coffee grounds passing dark, sticky, tar-like stools a sudden, sharp pain in your tummy that gets steadily worse These could be a sign of a serious complication, such as internal bleeding.

What causes stomach ulcers? This is usually a result of: an infection with Helicobacter pylori H.



0コメント

  • 1000 / 1000